mRNA vaccine platform

mRNA platforms encode the chosen neoantigens as messenger RNA wrapped in lipid nanoparticles. The patient's cells translate the mRNA, produce the neoantigen peptides, and present them — priming a T-cell response.

mRNA is attractive for personalized vaccines because a new sequence can be manufactured quickly once targets are chosen, making per-patient production more practical than older approaches.